This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Limb–girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive disorder associated with defects in the CAPN3 gene coding for calpain-3, a muscle-specific calcium-activated neutral protease.1 It is characterized by symmetric and selective atrophy and weakness of proximal limb muscles, elevated serum creatine kinase (CK) level, and dystrophic pattern on muscle biopsy.2,3⇓ Clinical differentiation from other LGMD may be difficult, and diagnosis is based mainly on mutation analysis of CAPN3. Monoclonal antibodies for blots have been developed, but there are not much data regarding the role of protein studies in diagnosis and the correlation between results of protein and genetic studies.4 We report a case of LGMD2A with mutations in the CAPN3 gene but no abnormality in the expression of calpain-3 protein on Western blots.
Case report.
A 43-year-old man had weakness in the proximal arm muscles for 10 years and had recently developed hip weakness. Physical examination revealed scapular winging, wasting of serratus anterior and trapezius muscles, and severe wasting of biceps and brachioradialis muscles with relative hypertrophy of the triceps and forearm muscles. Hamstrings and glutei were also severely affected, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Alert Me
Recommended articles
Limb-girdle muscular dystrophy in the Netherlands: Gene defect identified in half the families
Calpain III mutation analysis of a heterogeneous limb–girdle muscular dystrophy population
Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J
Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes